Data search
Results for MligTC455_37683
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_37683 | 97 | 2.03 | Mlig455_027754 | Neo: - Age: - |
KCNN2 | Mlig455_027754 {REF} {Length: 1617} {Pfam: Calmodulin binding domain [PF02888.18, score=117.1]; Ion channel [PF07885.18, score=49.9]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=359, Expect=1e-120]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=353, Expect=1e-120]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=343, Expect=4e-115]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=358, Expect=1e-120]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=353, Expect=2e-116]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=400, Expect=1e-137]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=303, Expect=2e-98]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [Score=355, Expect=1e-118]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_9828.1} |
Cumulative graph for MligTC455_37683
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -3.23 | 1.878 | 0.57832 | 1.00000 | |
| RegionR2 | 1 | 1.878 | 0.43072 | 0.82090 | |
| RegionR3 | 0.763 | 1.878 | 0.45362 | 0.96480 | |
| RegionR4 | -0.787 | 1.878 | 0.98072 | 1.00000 | |
| RegionR5 | -1.359 | 1.878 | 0.99589 | 1.00000 | |
| RegionR6 | -0.554 | 1.878 | 0.96501 | 1.00000 | |
| RegionR7 | 2.265 | 1.878 | 0.03088 | 0.33441 | |
| RegionR8 | 1.901 | 1.878 | 0.24641 | 0.86385 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -2.041 | 1.878 | 0.99985 | 1.00000 | |
| RegenerationR2 | 0.012 | 1.878 | 0.97975 | 1.00000 | |
| RegenerationR3 | -0.652 | 1.878 | 0.36771 | 0.78250 | |
| RegenerationR4 | -1.536 | 1.878 | 0.14665 | 0.57293 | |
| RegenerationR5 | 0.094 | 1.878 | 0.89517 | 1.00000 | |
| RegenerationR6 | -0.203 | 1.878 | 0.81535 | 0.98468 | |
| RegenerationBL | -2.861 | 1.878 | 0.02888 | 0.18878 | |
| RegenerationTP | -3.367 | 1.878 | 0.01810 | 0.23045 |
Genes with expression patterns similar to MligTC455_37683
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_37683 | 97 | 2.03 | Mlig455_027754 | Neo: - Age: - |
KCNN2 | 5 | - | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_027754 {REF} {Length: 1617} {Pfam: Calmodulin binding domain [PF02888.18, score=117.1]; Ion channel [PF07885.18, score=49.9]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=359, Expect=1e-120]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=353, Expect=1e-120]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=343, Expect=4e-115]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=358, Expect=1e-120]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=353, Expect=2e-116]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=400, Expect=1e-137]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=303, Expect=2e-98]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [Score=355, Expect=1e-118]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_9828.1} |
| 2. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 4.86 | - | 0.978 | 0.984 | 0.986 | 0.975 | 0.937 | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
| 3. | MligTC455_19509 | 232 | 4.83 | Mlig455_018973 | Neo: - |
HMCN1 | 2.694 | - | 0.847 | - | 0.883 | 0.964 | - | Mlig455_018973 {REF} {Length: 4775} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=103.1]; Immunoglobulin domain [PF13927.8, score=98.9]; Immunoglobulin domain [PF13895.8, score=66.1]; Immunoglobulin domain [PF00047.27, score=49.7]; Immunoglobulin V-set domain [PF07686.19, score=40.7]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=95.9, Expect=1e-19]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=97.8, Expect=2e-20]} {Dmel: FBgn0284408, trol, terribly reduced optic lobes, [Score=76.6, Expect=4e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=72.4, Expect=7e-13]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=86.3, Expect=2e-17]} {RNA1509_10174} {RNA1310_1561.1} {RNA815_4892} |
| 4. | MligTC455_48603 | 1006 | 20.95 | Mlig455_058556 | Neo: - Age: - Region-enriched R2: 1.380/0.01205 Regeneration-downregulated BL: -2.368 Regeneration-depleted BL: -2.368 |
CALM2 | 2.642 | - | 0.793 | - | 0.894 | 0.955 | - | Mlig455_058556 {REF} {Length: 2727} {TRANSSPLICED} {Pfam: EF-hand domain pair [PF13499.8, score=101.0]; EF hand [PF00036.34, score=97.2]; EF-hand domain pair [PF13833.8, score=81.7]; EF-hand domain [PF13405.8, score=78.5]; EF hand [PF13202.8, score=71.6]; EF-hand domain [PF14658.8, score=41.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.3]; Dockerin type I domain [PF00404.20, score=25.5]; SurA N-terminal domain [PF13624.8, score=19.1]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=132, Expect=1e-37]; ENSG00000160014, CALM3, calmodulin 3, [Score=130, Expect=5e-37]; ENSG00000198668, CALM1, calmodulin 1, [Score=130, Expect=3e-37]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=135, Expect=8e-39]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=130, Expect=3e-37]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=130, Expect=3e-37]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=127, Expect=3e-36]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=127, Expect=2e-36]} {Smed: dd_Smed_v6_12048_0_2, dd_Smed_v6_12048_0_2, [RH, Score=163, Expect=8e-49]} {RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1310_6210.2, RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1509_36324, RNA1509_52694, RNA1509_5720, RNA815_4293.1} |
| 5. | MligTC455_26832 | 211 | 4.39 | Mlig455_000690 | Neo: - Age: Down-Up-Down |
ANK3 | 2.631 | - | 0.762 | - | 0.916 | 0.953 | - | Mlig455_000690 {REF} {Length: 2225} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=184.0]; Ankyrin repeats (many copies) [PF13637.8, score=128.0]; Ankyrin repeat [PF00023.32, score=96.2]; Ankyrin repeats (many copies) [PF13857.8, score=94.5]; Ankyrin repeat [PF13606.8, score=92.4]; SOCS box [PF07525.18, score=29.0]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=120, Expect=6e-28]; ENSG00000135299, ANKRD6, ankyrin repeat domain 6, [Score=119, Expect=7e-28]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=122, Expect=1e-28]; ENSMUSG00000040183, Ankrd6, ankyrin repeat domain 6, [Score=122, Expect=6e-29]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=121, Expect=1e-28]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=97.4, Expect=6e-21]} {Smed: dd_Smed_v6_17293_0_1, dd_Smed_v6_17293_0_1, [RH, Score=549, Expect=0.0]} {RNA1509_43489} {RNA1310_16486.1} {RNA815_13229} |
| 6. | MligTC455_53466 | 67 | 1.39 | Mlig455_070695 | Neo: - Age: Up-Down-Down |
2.629 | - | - | - | 0.968 | 0.900 | 0.761 | Mlig455_070695 {REF} {Length: 2622} {Pfam: PDZ domain [PF00595.26, score=27.1]} {RNA1310_42258} {RNA815_27727} | |
| 7. | MligTC455_24993 | 233 | 4.86 | Mlig455_050468 | Neo: - Age: Up-Down-Down |
PTPRS | 2.611 | - | 0.828 | - | 0.828 | 0.955 | - | Mlig455_050468 {REF} {Length: 2099} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=259.3]; Tyrosine phosphatase family [PF13350.8, score=26.7]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=20.1]} {Human: ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [Score=499, Expect=3e-164]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [Score=494, Expect=1e-163]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [Score=500, Expect=7e-167]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [Score=493, Expect=2e-162]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [Score=491, Expect=9e-163]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [Score=454, Expect=7e-146]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [Score=318, Expect=9e-100]} {Smed: dd_Smed_v6_9734_0_1, dd_Smed_v6_9734_0_1, [Score=439, Expect=8e-146]} {RNA1509_59220} {RNA1310_403.1} {RNA815_2245.3} |
| 8. | MligTC455_24992 | 222 | 4.62 | Mlig455_040423 | Neo: - Age: Up-Down-Down |
PTPRD | 2.594 | - | 0.794 | - | 0.831 | 0.969 | - | Mlig455_040423 {REF} {Length: 5511} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=536.0]; Fibronectin type III domain [PF00041.23, score=69.6]; Tyrosine phosphatase family [PF13350.8, score=37.9]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=33.7]; Inositol hexakisphosphate [PF14566.8, score=24.3]} {Human: ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [RH, Score=1010, Expect=0.0]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [RH, Score=1009, Expect=0.0]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [RH, Score=1023, Expect=0.0]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [RH, Score=1011, Expect=0.0]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [RH, Score=1004, Expect=0.0]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [RH, Score=928, Expect=0.0]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [RH, Score=723, Expect=0.0]} {Smed: dd_Smed_v6_10176_0_2, dd_Smed_v6_10176_0_2, [RH, Score=962, Expect=0.0]} {RNA1509_45823, RNA1509_59220} {RNA1310_2694.1, RNA1509_45823, RNA1509_59220} {RNA1509_45823, RNA1509_59220, RNA815_2245.1} |
| 9. | MligTC455_41823 | 300 | 6.25 | Mlig455_022277 | Neo: - Age: - Region-enriched R2: 3.150/0.00185 |
2.594 | - | - | - | 0.874 | 0.958 | 0.762 | Mlig455_022277 {REF} {Length: 753} {RNA1509_49797} {RNA1310_60350} {RNA815_30999} | |
| 10. | MligTC455_43181 | 570 | 11.88 | Mlig455_000235, Mlig455_058496 | Neo: - Age: Up-Down-Down |
GABRG2 | 2.566 | - | 0.790 | - | 0.821 | 0.955 | - | Mlig455_000235 {REF} {Length: 2985} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=28.7]} {Human: ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=71.2, Expect=9e-13]; ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=68.6, Expect=2e-11]; ENSG00000163285, GABRG1, gamma-aminobutyric acid type A receptor gamma1 subunit, [Score=68.6, Expect=2e-11]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=72.0, Expect=1e-12]; ENSMUSG00000001260, Gabrg1, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1, [Score=70.1, Expect=6e-12]; ENSMUSG00000020436, Gabrg2, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2, [Score=69.7, Expect=7e-12]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_10171_0_2, dd_Smed_v6_10171_0_2, [Score=440, Expect=3e-144]} {RNA1509_31476} {RNA1310_7448.1} {RNA815_6894} Mlig455_058496 {REF} {Length: 3260} {Smed: dd_Smed_v6_13861_0_2, dd_Smed_v6_13861_0_2, [RH, Score=91.3, Expect=2e-23]} {RNA1509_31476} {RNA1310_7448.1} {RNA815_11721.1} |
| 11. | MligTC455_44094 | 90 | 1.88 | Mlig455_018759 | Neo: - Age: - |
PCDH17 | 2.561 | - | - | - | 0.862 | 0.965 | 0.734 | Mlig455_018759 {REF} {Length: 3612} {Pfam: Cadherin domain [PF00028.19, score=240.7]; Cadherin-like [PF16184.7, score=28.6]; Cadherin-like [PF08266.14, score=27.8]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [RH, Score=263, Expect=1e-73]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [RH, Score=264, Expect=7e-73]; ENSMUSG00000051323, Pcdh19, protocadherin 19, [RH, Score=261, Expect=6e-72]; ENSMUSG00000104063, Pcdhgb7, protocadherin gamma subfamily B, 7, [RH, Score=260, Expect=2e-72]} {Dmel: FBgn0024836, stan, starry night, [Score=215, Expect=1e-56]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=176, Expect=2e-44]} {Smed: dd_Smed_v6_21489_0_1, dd_Smed_v6_21489_0_1, [Score=283, Expect=5e-81]} {RNA1509_38737} {RNA1310_26793, RNA1509_38737} {RNA1509_38737, RNA815_46826} |
| 12. | MligTC455_04162 | 131 | 2.73 | Mlig455_028924 | Neo: - |
HMCN1 | 2.49 | - | 0.707 | - | 0.827 | 0.956 | - | Mlig455_028924 {REF} {Length: 3929} {Pfam: Immunoglobulin domain [PF13927.8, score=144.9]; Immunoglobulin I-set domain [PF07679.18, score=119.8]; Immunoglobulin domain [PF13895.8, score=113.4]; Immunoglobulin domain [PF00047.27, score=102.3]; Immunoglobulin V-set domain [PF07686.19, score=36.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=35.3]; Immunoglobulin C1-set domain [PF07654.17, score=23.3]; C17orf99 Ig domain [PF17736.3, score=20.9]; Immunoglobulin domain [PF18452.3, score=19.8]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=103, Expect=2e-21]; ENSG00000148357, HMCN2, hemicentin 2, [Score=100, Expect=8e-21]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=107, Expect=5e-23]; ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=103, Expect=7e-22]} {Dmel: FBgn0000547, ed, echinoid, [Score=147, Expect=2e-35]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=100, Expect=3e-21]} {Smed: dd_Smed_v6_13903_0_1, dd_Smed_v6_13903_0_1, [Score=162, Expect=2e-40]} {RNA1310_26618} {RNA815_41641} |
| 13. | MligTC455_37010 | 127 | 2.64 | Mlig455_012355 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.232/0.00085 |
2.457 | - | 0.719 | - | 0.964 | 0.774 | - | Mlig455_012355 {REF} {Length: 7737} {Pfam: HGWP repeat [PF03578.17, score=19.0]} {RNA1509_28298} {RNA1310_3268} {RNA815_628} | |
| 14. | MligTC455_29202 | 397 | 8.26 | Mlig455_016520 | Neo: - Age: Up-Down-Up |
OTOF | 2.437 | - | - | - | 0.724 | 0.964 | 0.749 | Mlig455_016520 {REF} {Length: 3035} {Pfam: C2 domain [PF00168.32, score=46.4]} {Human: ENSG00000115155, OTOF, otoferlin, [Score=310, Expect=3e-90]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [Score=302, Expect=6e-88]} {Dmel: FBgn0266757, mfr, misfire, [Score=131, Expect=1e-31]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=73.6, Expect=4e-13]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=452, Expect=6e-140]} {RNA1509_5256} {RNA1310_1035} {RNA815_411.1} |
| 15. | MligTC455_29201 | 1280 | 26.67 | Mlig455_049817 | Neo: - Age: - Regeneration-downregulated BL: -1.729 Regeneration-depleted BL: -1.729 |
OTOF | 2.403 | - | - | - | 0.702 | 0.979 | 0.722 | Mlig455_049817 {REF} {Length: 7973} {Pfam: C2 domain [PF00168.32, score=225.3]; FerB (NUC096) domain [PF08150.14, score=99.1]; Ferlin C-terminus [PF16165.7, score=97.7]; FerI (NUC094) domain [PF08151.14, score=61.5]} {Human: ENSG00000115155, OTOF, otoferlin, [RH, Score=910, Expect=0.0]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [RH, Score=915, Expect=0.0]} {Dmel: FBgn0266757, mfr, misfire, [RH, Score=301, Expect=4e-84]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=150, Expect=9e-36]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=1476, Expect=0.0]} {RNA1509_5256} {RNA1310_1416.2} {RNA815_411.1} |
| 16. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 1.893 | - | - | - | 0.935 | 0.958 | - | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
| 17. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
1.887 | - | - | - | 0.906 | 0.981 | - | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
| 18. | MligTC455_17018 | 93 | 1.93 | Mlig455_008015 | Neo: - Age: logFC(26M/2M)=1.300 |
1.881 | - | - | - | 0.899 | 0.982 | - | Mlig455_008015 {REF} {Length: 1919} {TRANSSPLICED} {Pfam: Sleepless protein [PF17064.7, score=37.0]} {Dmel: FBgn0260499, qvr, quiver, [Score=69.7, Expect=2e-15]} {Smed: dd_Smed_v6_16907_0_2, dd_Smed_v6_16907_0_2, [Score=74.7, Expect=1e-17]} {RNA1310_61248} {RNA815_27518} | |
| 19. | MligTC455_37315 | 84 | 1.76 | Mlig455_048842 | Neo: - Age: - |
CALM2 | 1.871 | - | - | - | 0.900 | 0.971 | - | Mlig455_048842 {REF} {Length: 1287} {Pfam: EF-hand domain pair [PF13499.8, score=22.7]; EF-hand domain [PF14658.8, score=19.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=68.9, Expect=6e-14]; ENSG00000198668, CALM1, calmodulin 1, [Score=68.2, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=66.6, Expect=2e-13]; ENSG00000178363, CALML3, calmodulin like 3, [Score=65.5, Expect=4e-13]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=2e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=66.6, Expect=1e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=66.6, Expect=1e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=68.6, Expect=1e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=68.6, Expect=1e-14]} {Smed: dd_Smed_v6_5491_0_1, dd_Smed_v6_5491_0_1, [Score=110, Expect=3e-30]} {RNA1310_33365} {RNA815_27013} |
| 20. | MligTC455_24064 | 359 | 7.48 | Mlig455_048183 | Neo: - Age: - |
SNAP25 | 1.863 | - | - | - | 0.893 | 0.970 | - | Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439} |
| 21. | MligTC455_29118 | 467 | 9.72 | Mlig455_040411 | Neo: - Age: - Region-specific R2: 6.456 Region-enriched R2: 5.344/0.00023 |
1.857 | - | - | - | 0.897 | 0.960 | - | Mlig455_040411 {REF} {Length: 599} {TRANSSPLICED} {RNA1509_53840} {RNA1310_67192, RNA1509_53840} {RNA1509_53840, RNA815_27042} | |
| 22. | MligTC455_44661 | 48 | 1 | Mlig455_038182 | Neo: - Age: logFC(26M/2M)=-0.564 |
ANO7 | 1.857 | - | - | - | 0.893 | 0.964 | - | Mlig455_038182 {REF} {Length: 3290} {Pfam: Calcium-activated chloride channel [PF04547.14, score=599.2]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=223.8]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=572, Expect=0.0]} {Dmel: FBgn0038721, subdued, [Score=422, Expect=3e-132]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=163, Expect=4e-41]} {Smed: dd_Smed_v6_19189_0_1, dd_Smed_v6_19189_0_1, [Score=670, Expect=0.0]} {RNA1509_46639} {RNA1310_1412.2} {RNA815_15650} |
| 23. | MligTC455_40714 | 93 | 1.94 | Mlig455_008848 | Neo: - Age: - Region-enriched R2: 5.100/0.02617 |
1.856 | - | - | - | 0.899 | 0.957 | - | Mlig455_008848 {REF} {Length: 2258} {RNA1310_21537} {RNA815_13165} | |
| 24. | MligTC455_22214 | 237 | 4.94 | Mlig455_019333, Mlig455_019447 | Neo: - Age: - |
NRG2 | 1.852 | - | - | - | 0.887 | 0.965 | - | Mlig455_019333 {REF} {Length: 4291} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=50.5]; Immunoglobulin domain [PF13927.8, score=44.7]; Immunoglobulin domain [PF00047.27, score=43.9]; Immunoglobulin domain [PF13895.8, score=22.0]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=86.7, Expect=8e-17]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [RH, Score=81.3, Expect=2e-15]} {Dmel: FBgn0005666, bt, bent, [Score=52.0, Expect=2e-06]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=51.2, Expect=3e-06]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [Score=55.1, Expect=9e-08]} {RNA1509_54517} {RNA1310_8322} {RNA815_13786} Mlig455_019447 {REF} {Length: 4242} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=50.5]; Immunoglobulin domain [PF13927.8, score=44.8]; Immunoglobulin domain [PF00047.27, score=43.9]; Immunoglobulin domain [PF13895.8, score=22.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=18.6]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=88.6, Expect=2e-17]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [RH, Score=83.2, Expect=7e-16]} {Dmel: FBgn0005666, bt, bent, [Score=52.4, Expect=2e-06]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=51.2, Expect=3e-06]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [Score=55.1, Expect=9e-08]} {RNA1509_54517} {RNA1310_8322} {RNA815_13786} |
| 25. | MligTC455_46793 | 652 | 13.58 | Mlig455_058553 | Neo: - Age: - |
SYTL4 | 1.847 | - | - | - | 0.888 | 0.959 | - | Mlig455_058553 {REF} {Length: 2601} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=103.1]} {Human: ENSG00000102362, SYTL4, synaptotagmin like 4, [Score=153, Expect=2e-38]; ENSG00000147041, SYTL5, synaptotagmin like 5, [Score=150, Expect=2e-37]; ENSG00000142765, SYTL1, synaptotagmin like 1, [Score=149, Expect=1e-37]} {Mouse: ENSMUSG00000031255, Sytl4, synaptotagmin-like 4, [Score=160, Expect=6e-41]} {Dmel: FBgn0266756, btsz, bitesize, [Score=193, Expect=2e-51]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=86.3, Expect=1e-17]} {Smed: dd_Smed_v6_10375_0_1, dd_Smed_v6_10375_0_1, [RH, Score=157, Expect=3e-40]} {RNA1509_50455} {RNA1310_5507.1, RNA1509_50455} {RNA1509_50455, RNA815_17811} |
| 26. | MligTC455_35739 | 91 | 1.9 | Mlig455_050779 | Neo: - Age: Up-Down-Down |
ADGRL2 | 1.846 | - | - | - | 0.883 | 0.963 | - | Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153} |
| 27. | MligTC455_45191 | 1420 | 29.58 | Mlig455_000192, Mlig455_058450, Mlig455_067701 | Neo: - Age: - Regeneration-downregulated BL: -2.403 Regeneration-depleted BL: -2.403 |
BSG | 1.845 | - | - | - | 0.895 | 0.950 | - | Mlig455_000192 {REF} {Length: 2540} {Pfam: Immunoglobulin domain [PF13927.8, score=57.1]; Immunoglobulin I-set domain [PF07679.18, score=53.6]; Immunoglobulin domain [PF00047.27, score=36.0]; Immunoglobulin domain [PF13895.8, score=30.4]; Immunoglobulin V-set domain [PF07686.19, score=22.2]} {Human: ENSG00000172270, BSG, basigin (Ok blood group), [Score=67.8, Expect=1e-12]} {Mouse: ENSMUSG00000023175, Bsg, basigin, [Score=82.4, Expect=3e-17]} {Dmel: FBgn0261822, Bsg, Basigin, [RH, Score=61.6, Expect=1e-10]} {Celegans: WBGene00004729, sax-3, [Score=57.4, Expect=6e-09]} {Smed: dd_Smed_v6_1827_0_1, dd_Smed_v6_1827_0_1, [Score=81.6, Expect=9e-18]} {RNA1509_31454, RNA1509_47270} {RNA1310_8812, RNA1509_31454, RNA1509_47270} {RNA1509_31454, RNA1509_47270, RNA815_2422} Mlig455_058450 {REF} {Length: 3207} {Pfam: Immunoglobulin domain [PF13927.8, score=56.4]; Immunoglobulin I-set domain [PF07679.18, score=53.0]; Immunoglobulin domain [PF00047.27, score=36.1]; Immunoglobulin domain [PF13895.8, score=29.3]; Immunoglobulin V-set domain [PF07686.19, score=22.0]} {Human: ENSG00000172270, BSG, basigin (Ok blood group), [Score=67.4, Expect=2e-12]} {Mouse: ENSMUSG00000023175, Bsg, basigin, [Score=81.6, Expect=6e-17]} {Dmel: FBgn0261822, Bsg, Basigin, [RH, Score=62.4, Expect=6e-11]} {Celegans: WBGene00004729, sax-3, [Score=58.5, Expect=3e-09]} {Smed: dd_Smed_v6_1827_0_1, dd_Smed_v6_1827_0_1, [Score=80.5, Expect=3e-17]} {RNA1509_31454} {RNA1310_8812} {RNA815_2422} Mlig455_067701 {REF} {Length: 2864} {Celegans: WBGene00018026, F35A5.4, [Score=60.1, Expect=8e-11]} {RNA1509_47270} {RNA1310_8812} {RNA815_2422} |
| 28. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
1.841 | - | - | - | 0.885 | 0.956 | - | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
| 29. | MligTC455_09313 | 673 | 14.01 | Mlig455_021865, Mlig455_021943 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.967/0.00176 |
1.84 | - | - | - | 0.886 | 0.954 | - | Mlig455_021865 {REF} {Length: 5096} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [Score=79.3, Expect=1e-14]} {RNA1509_22941} {RNA1310_4839.1} {RNA815_8984} Mlig455_021943 {REF} {Length: 5863} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [RH, Score=83.6, Expect=7e-16]} {RNA1509_22941} {RNA1310_4839.1, RNA1509_22941} {RNA1509_22941, RNA815_15728} |
|
| 30. | MligTC455_19040 | 49 | 1.03 | Mlig455_003437 | Neo: - Age: - Region-enriched R2: 6.133/0.00615 |
CAV1 | 1.829 | - | - | - | 0.855 | 0.974 | - | Mlig455_003437 {REF} {Length: 808} {Pfam: Caveolin [PF01146.19, score=118.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=101, Expect=7e-28]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=102, Expect=2e-28]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.6, Expect=9e-17]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=142, Expect=8e-45]} {RNA1509_53381} {RNA1310_97043} {RNA815_32565} |
| 31. | MligTC455_25914 | 4684 | 97.58 | Mlig455_004975 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.418 Region-enriched R2: 1.471/0.00163 Regeneration-downregulated BL: -1.843 Regeneration-depleted BL: -1.843 |
1.82 | - | - | - | 0.865 | 0.955 | - | Mlig455_004975 {REF} {Length: 5220} {RNA1509_1158, RNA1509_11723} {RNA1310_4621.1, RNA1509_11723} {RNA1509_11723, RNA815_1336.1} | |
| 32. | MligTC455_25915 | 4499 | 93.72 | Mlig455_005297 | Neo: - Age: - Region-enriched R2: 1.495/0.00336 Regeneration-downregulated BL: -1.833 Regeneration-depleted BL: -1.833 |
CPE | 1.819 | - | - | - | 0.865 | 0.954 | - | Mlig455_005297 {REF} {Length: 3239} {Pfam: Zinc carboxypeptidase [PF00246.26, score=188.0]; Carboxypeptidase regulatory-like domain [PF13620.8, score=23.3]} {Human: ENSG00000109472, CPE, carboxypeptidase E, [Score=322, Expect=8e-105]} {Mouse: ENSMUSG00000037852, Cpe, carboxypeptidase E, [Score=318, Expect=1e-103]} {Dmel: FBgn0004648, svr, silver, [Score=225, Expect=2e-68]} {Celegans: WBGene00001189, egl-21, Carboxypeptidase E, [RH, Score=333, Expect=5e-110]} {Smed: dd_Smed_v6_3059_0_1, dd_Smed_v6_3059_0_1, [RH, Score=384, Expect=7e-130]} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1310_4621.1, RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908, RNA815_1336.1} |
| 33. | MligTC455_45880 | 278 | 5.8 | Mlig455_051498 | Neo: - Age: - Region-enriched R2: 5.081/0.00218 |
CALM2 | 1.812 | - | 0.858 | - | - | 0.954 | - | Mlig455_051498 {REF} {Length: 2328} {Pfam: EF-hand domain pair [PF13499.8, score=48.0]; EF-hand domain [PF14658.8, score=32.2]; EF-hand domain [PF13405.8, score=23.0]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=84.0, Expect=1e-20]; ENSG00000160014, CALM3, calmodulin 3, [Score=84.0, Expect=1e-20]; ENSG00000198668, CALM1, calmodulin 1, [Score=84.0, Expect=1e-20]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=84.0, Expect=9e-21]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=84.0, Expect=9e-21]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=84.0, Expect=9e-21]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=82.8, Expect=2e-20]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=82.8, Expect=1e-20]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=82.8, Expect=9e-21]} {RNA1509_41430} {RNA1310_44424} {RNA815_28870} |
| 34. | MligTC455_35411 | 583 | 12.15 | Mlig455_064235 | Neo: - Age: - |
PPP3CA | 1.8 | - | - | - | 0.839 | 0.961 | - | Mlig455_064235 {REF} {Length: 3595} {Human: ENSG00000138814, PPP3CA, protein phosphatase 3 catalytic subunit alpha, [Score=156, Expect=8e-46]; ENSG00000107758, PPP3CB, protein phosphatase 3 catalytic subunit beta, [Score=149, Expect=4e-43]} {Mouse: ENSMUSG00000028161, Ppp3ca, protein phosphatase 3, catalytic subunit, alpha isoform, [Score=158, Expect=1e-46]} {Dmel: FBgn0011826, Pp2B-14D, Protein phosphatase 2B at 14D, [Score=159, Expect=1e-46]} {Celegans: WBGene00006527, tax-6, Serine/threonine-protein phosphatase 2B catalytic subunit, [Score=115, Expect=1e-30]} {Smed: dd_Smed_v6_5669_1_2, dd_Smed_v6_5669_1_2, [Score=155, Expect=7e-49]} {RNA1509_42566} {RNA1310_30586} {RNA815_21103.2} |
| 35. | MligTC455_16866 | 18 | 0.37 | Mlig455_065296 | Neo: - Age: - |
1.781 | - | - | - | 0.818 | 0.963 | - | Mlig455_065296 {REF} {Length: 1827} {RNA1310_92472} | |
| 36. | MligTC455_16867 | 18 | 0.37 | Mlig455_065319 | Neo: - Age: - |
1.781 | - | - | - | 0.818 | 0.963 | - | Mlig455_065319 {REF} {Length: 1743} {RNA1310_92472} | |
| 37. | MligTC455_05969 | 143 | 2.98 | Mlig455_008036, Mlig455_008076 | Neo: - Age: Up-Down-Up |
CHRM3 | 1.772 | - | - | - | 0.821 | 0.951 | - | Mlig455_008036 {REF} {Length: 4356} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=235.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=49.3]; Olfactory receptor [PF13853.8, score=29.1]} {Human: ENSG00000133019, CHRM3, cholinergic receptor muscarinic 3, [Score=252, Expect=3e-75]} {Mouse: ENSMUSG00000046159, Chrm3, cholinergic receptor, muscarinic 3, cardiac, [Score=248, Expect=3e-74]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [RH, Score=216, Expect=9e-61]} {Celegans: WBGene00001519, gar-3, Muscarinic acetylcholine receptor gar-3, [RH, Score=246, Expect=2e-73]} {Smed: dd_Smed_v6_20043_0_1, dd_Smed_v6_20043_0_1, [RH, Score=243, Expect=3e-73]} {RNA1509_25623} {RNA1310_4787.1} {RNA815_38888} Mlig455_008076 {REF} {Length: 6010} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=260.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=48.6]; Olfactory receptor [PF13853.8, score=28.2]} {Human: ENSG00000133019, CHRM3, cholinergic receptor muscarinic 3, [RH, Score=306, Expect=1e-95]} {Mouse: ENSMUSG00000046159, Chrm3, cholinergic receptor, muscarinic 3, cardiac, [RH, Score=302, Expect=3e-94]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [RH, Score=215, Expect=4e-60]} {Celegans: WBGene00001519, gar-3, Muscarinic acetylcholine receptor gar-3, [RH, Score=307, Expect=2e-96]} {Smed: dd_Smed_v6_20043_0_1, dd_Smed_v6_20043_0_1, [RH, Score=303, Expect=1e-95]} {RNA1509_25623} {RNA1310_4787.1, RNA1509_25623} {RNA1509_25623, RNA815_17017} |
| 38. | MligTC455_49620 | 290 | 6.04 | Mlig455_001138, Mlig455_001300 | Neo: - Age: - Region-enriched R2: 5.198/0.00000 |
ELAVL3, ELAVL4 | 1.767 | - | - | - | 0.816 | 0.951 | - | Mlig455_001138 {REF} {Length: 3131} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=206.7]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=37.5]; Occluded RNA-recognition motif [PF16842.7, score=27.0]} {Human: ENSG00000162374, ELAVL4, ELAV like RNA binding protein 4, [Score=268, Expect=6e-85]; ENSG00000196361, ELAVL3, ELAV like RNA binding protein 3, [Score=268, Expect=3e-85]; ENSG00000107105, ELAVL2, ELAV like RNA binding protein 2, [Score=268, Expect=2e-84]} {Mouse: ENSMUSG00000003410, Elavl3, ELAV like RNA binding protein 3, [RH, Score=270, Expect=2e-87]} {Dmel: FBgn0010263, Rbp9, RNA-binding protein 9, [Score=273, Expect=2e-86]} {Celegans: WBGene00001368, exc-7, [RH, Score=327, Expect=6e-107]} {Smed: dd_Smed_v6_13151_0_1, dd_Smed_v6_13151_0_1, [RH, Score=269, Expect=8e-84]} {RNA1509_28072} {RNA1310_22289} {RNA815_15133} Mlig455_001300 {REF} {Length: 3150} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=203.6]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=36.4]; Occluded RNA-recognition motif [PF16842.7, score=27.0]} {Human: ENSG00000196361, ELAVL3, ELAV like RNA binding protein 3, [Score=274, Expect=4e-87]; ENSG00000162374, ELAVL4, ELAV like RNA binding protein 4, [Score=271, Expect=6e-86]; ENSG00000107105, ELAVL2, ELAV like RNA binding protein 2, [Score=268, Expect=3e-85]; ENSG00000066044, ELAVL1, ELAV like RNA binding protein 1, [Score=262, Expect=3e-83]} {Mouse: ENSMUSG00000003410, Elavl3, ELAV like RNA binding protein 3, [RH, Score=271, Expect=7e-88]} {Dmel: FBgn0010263, Rbp9, RNA-binding protein 9, [Score=270, Expect=4e-85]} {Celegans: WBGene00001368, exc-7, [RH, Score=326, Expect=1e-106]} {Smed: dd_Smed_v6_11311_0_2, dd_Smed_v6_11311_0_2, [RH, Score=300, Expect=2e-97]} {RNA1509_28072} {RNA1310_22289} {RNA815_15133} |
| 39. | MligTC455_53382 | 110 | 2.28 | Mlig455_006777 | Neo: - Age: - |
1.753 | - | - | - | 0.802 | 0.951 | - | Mlig455_006777 {REF} {Length: 2841} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.8]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=48.9, Expect=1e-05]} {Smed: dd_Smed_v6_8885_0_1, dd_Smed_v6_8885_0_1, [Score=137, Expect=6e-36]} {RNA1509_47534} {RNA1310_15311} {RNA815_12841} | |
| 40. | MligTC455_24070 | 770 | 16.04 | Mlig455_038826, Mlig455_038914 | Neo: - Age: Down-Up-Down |
1.743 | - | 0.786 | - | - | 0.957 | - | Mlig455_038826 {REF} {Length: 1863} {RNA1509_15528} {RNA1310_31818} {RNA815_10793} Mlig455_038914 {REF} {Length: 2695} {RNA1509_15528} {RNA1310_31818} {RNA815_10793} |
|
| 41. | MligTC455_35769 | 90 | 1.87 | Mlig455_034140, Mlig455_050376, Mlig455_062180 | Neo: - |
1.739 | - | 0.783 | - | - | 0.956 | - | Mlig455_034140 {REF} {Length: 1714} {RNA1509_25690} {RNA1310_57234} {RNA815_17883} Mlig455_050376 {REF} {Length: 2093} {TRANSSPLICED} {RNA1509_54944} {RNA1310_23258} {RNA815_47172} Mlig455_062180 {REF} {Length: 90} {NoTransDecoderORF} {RNA1509_25690} {RNA1310_65891} {RNA815_17883} |
|
| 42. | MligTC455_29667 | 109 | 2.27 | Mlig455_024022 | Neo: - Age: - |
PARD3 | 1.721 | - | - | - | 0.757 | 0.964 | - | Mlig455_024022 {REF} {Length: 5978} {Pfam: PDZ domain [PF00595.26, score=55.5]; PDZ domain [PF17820.3, score=28.7]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=18.7]} {Human: ENSG00000148498, PARD3, par-3 family cell polarity regulator, [Score=95.5, Expect=2e-19]; ENSG00000116117, PARD3B, par-3 family cell polarity regulator beta, [Score=92.8, Expect=1e-18]} {Mouse: ENSMUSG00000025812, Pard3, par-3 family cell polarity regulator, [Score=100, Expect=5e-21]} {Dmel: FBgn0000163, baz, bazooka, [Score=76.3, Expect=9e-14]} {Celegans: WBGene00003516, nab-1, NeurABin, [Score=69.7, Expect=5e-12]} {Smed: dd_Smed_v6_11296_0_2, dd_Smed_v6_11296_0_2, [Score=79.7, Expect=4e-15]} {RNA1509_51660} {RNA1310_2804} {RNA815_25384} |
| 43. | MligTC455_12992 | 102 | 2.12 | Mlig455_034920 | Neo: - Age: - Region-enriched R2: 3.155/0.02568 |
RAC2 | 1.718 | - | - | - | 0.754 | 0.964 | - | Mlig455_034920 {REF} {Length: 3245} {Pfam: Ras family [PF00071.24, score=175.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=80.0]; ADP-ribosylation factor family [PF00025.23, score=32.7]} {Human: ENSG00000128340, RAC2, Rac family small GTPase 2, [Score=277, Expect=1e-95]; ENSG00000136238, RAC1, Rac family small GTPase 1, [Score=273, Expect=6e-94]} {Mouse: ENSMUSG00000033220, Rac2, Rac family small GTPase 2, [Score=275, Expect=3e-95]; ENSMUSG00000001847, Rac1, Rac family small GTPase 1, [Score=273, Expect=4e-94]; ENSMUSG00000018012, Rac3, Rac family small GTPase 3, [Score=263, Expect=3e-90]} {Dmel: FBgn0010333, Rac1, [Score=270, Expect=2e-93]} {Celegans: WBGene00000424, ced-10, Ras-related protein ced-10, [Score=268, Expect=2e-92]} {Smed: dd_Smed_v6_610_0_1, dd_Smed_v6_610_0_1, [Score=251, Expect=4e-86]} {RNA1509_26483} {RNA1310_31644} {RNA815_16762} |
| 44. | MligTC455_25378 | 134 | 2.8 | Mlig455_016116 | Neo: - Age: - Region-enriched R7: 3.311/0.00287 |
TNS2 | 1.705 | - | - | - | 0.750 | 0.955 | - | Mlig455_016116 {REF} {Length: 2694} {Pfam: SH2 domain [PF00017.26, score=30.8]; Phosphotyrosine-binding domain [PF08416.15, score=22.5]} {Human: ENSG00000111077, TNS2, tensin 2, [Score=95.9, Expect=5e-20]} {Mouse: ENSMUSG00000037003, Tns2, tensin 2, [Score=90.1, Expect=2e-18]} {Smed: dd_Smed_v6_4454_0_2, dd_Smed_v6_4454_0_2, [Score=97.4, Expect=3e-21]} {RNA1509_44612} {RNA1310_9162.1} {RNA815_10953} |
| 45. | MligTC455_19578 | 23 | 0.47 | Mlig455_018093, Mlig455_059526 | Neo: - Age: - |
1.703 | - | - | - | 0.737 | 0.966 | - | Mlig455_018093 {REF} {Length: 2450} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=99.2]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=72.4, Expect=4e-13]} {RNA1310_65251} Mlig455_059526 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=74.7, Expect=8e-14]} {RNA1310_65251} |
|
| 46. | MligTC455_13512 | 156 | 3.24 | Mlig455_020307 | Neo: - Age: - |
CNGA3 | 1.702 | - | - | - | 0.742 | 0.960 | - | Mlig455_020307 {REF} {Length: 3017} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=63.0]; Ion transport protein [PF00520.33, score=56.3]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=430, Expect=3e-138]; ENSG00000183862, CNGA2, cyclic nucleotide gated channel alpha 2, [Score=412, Expect=6e-132]; ENSG00000198515, CNGA1, cyclic nucleotide gated channel alpha 1, [Score=412, Expect=2e-131]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=414, Expect=6e-133]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=410, Expect=6e-131]; ENSMUSG00000005864, Cnga2, cyclic nucleotide gated channel alpha 2, [Score=402, Expect=3e-128]} {Dmel: FBgn0259145, CG42260, [RH, Score=652, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=352, Expect=7e-109]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=404, Expect=1e-129]} {RNA1509_58266} {RNA1310_19338} {RNA815_12776} |
| 47. | MligTC455_19809 | 798 | 16.63 | Mlig455_060372 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.288 Region-enriched R2: 1.440/0.00492 |
CACNA1C | 1.698 | - | - | - | 0.953 | 0.745 | - | Mlig455_060372 {REF} {Length: 8744} {Pfam: Ion transport protein [PF00520.33, score=796.8]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=96.5]; Voltage gated calcium channel IQ domain [PF08763.13, score=95.7]; Polycystin cation channel [PF08016.14, score=39.1]} {Human: ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1289, Expect=0.0]; ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1289, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=1281, Expect=0.0]; ENSG00000102001, CACNA1F, calcium voltage-gated channel subunit alpha1 F, [Score=1260, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=1254, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=1304, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=1273, Expect=0.0]; ENSMUSG00000031142, Cacna1f, calcium channel, voltage-dependent, alpha 1F subunit, [Score=1270, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=1259, Expect=0.0]} {Dmel: FBgn0263111, cac, cacophony, [RH, Score=1845, Expect=0.0]} {Celegans: WBGene00006742, unc-2, High voltage activated calcium channel alpha-1 subunit, [RH, Score=1742, Expect=0.0]} {Smed: dd_Smed_v6_13295_0_1, dd_Smed_v6_13295_0_1, [RH, Score=2169, Expect=0.0]} {RNA1509_13061} {RNA1310_6260.1} {RNA815_730.1} |
| 48. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 1.697 | - | - | - | - | 0.966 | 0.731 | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
| 49. | MligTC455_13403 | 157 | 3.27 | Mlig455_058321 | Neo: - Age: Down-Up-Down Region-enriched R2: 2.878/0.03174 |
LARP1 | 1.696 | - | - | - | 0.736 | 0.960 | - | Mlig455_058321 {REF} {Length: 2328} {Human: ENSG00000155506, LARP1, La ribonucleoprotein domain family member 1, [Score=178, Expect=6e-52]} {Mouse: ENSMUSG00000037331, Larp1, La ribonucleoprotein domain family, member 1, [Score=178, Expect=5e-52]; ENSMUSG00000025762, Larp1b, La ribonucleoprotein domain family, member 1B, [Score=171, Expect=9e-54]} {Dmel: FBgn0261618, larp, La related protein, [Score=172, Expect=4e-50]} {Celegans: WBGene00020097, larp-1, La-related protein 1, [Score=136, Expect=2e-37]} {Smed: dd_Smed_v6_2667_0_1, dd_Smed_v6_2667_0_1, [Score=170, Expect=2e-49]} {RNA1509_29509} {RNA1310_3597.2, RNA1509_29509} {RNA1509_29509, RNA815_2607} |
| 50. | MligTC455_38158 | 2649 | 55.19 | Mlig455_017146, Mlig455_019684 | Neo: - Age: - |
ABCA1 | 1.689 | - | - | - | 0.723 | 0.966 | - | Mlig455_017146 {REF} {Length: 8261} {TRANSSPLICED} {Pfam: ABC transporter [PF00005.29, score=164.2]; ABC-2 family transporter protein [PF12698.9, score=163.8]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=67.7]} {Human: ENSG00000165029, ABCA1, ATP binding cassette subfamily A member 1, [Score=1144, Expect=0.0]} {Mouse: ENSMUSG00000015243, Abca1, ATP-binding cassette, sub-family A (ABC1), member 1, [Score=1146, Expect=0.0]} {Dmel: FBgn0031170, CG1718, [Score=440, Expect=5e-126]} {Celegans: WBGene00000022, abt-4, ABC Transporter family, [Score=367, Expect=2e-102]} {Smed: dd_Smed_v6_2300_0_3, dd_Smed_v6_2300_0_3, [Score=1041, Expect=0.0]} {RNA1509_5078} {RNA1310_229.1, RNA1509_5078} {RNA1509_5078, RNA815_12546} Mlig455_019684 {REF} {Length: 8212} {Pfam: ABC-2 family transporter protein [PF12698.9, score=166.6]; ABC transporter [PF00005.29, score=164.4]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=64.8]; AAA domain [PF13476.8, score=20.2]} {Human: ENSG00000165029, ABCA1, ATP binding cassette subfamily A member 1, [Score=1155, Expect=0.0]} {Mouse: ENSMUSG00000015243, Abca1, ATP-binding cassette, sub-family A (ABC1), member 1, [Score=1156, Expect=0.0]} {Dmel: FBgn0031170, CG1718, [Score=436, Expect=1e-124]} {Celegans: WBGene00000022, abt-4, ABC Transporter family, [Score=367, Expect=2e-102]} {Smed: dd_Smed_v6_2300_0_4, dd_Smed_v6_2300_0_4, [Score=1075, Expect=0.0]} {RNA1509_5078} {RNA1310_229.1} {RNA815_12546} |
| 51. | MligTC455_24910 | 147 | 3.05 | Mlig455_064485 | Neo: - |
1.687 | - | - | - | - | 0.965 | 0.722 | Mlig455_064485 {REF} {Length: 3010} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=37.7]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=157, Expect=2e-41]} {RNA1509_58255} {RNA1310_11401, RNA1509_58255} {RNA1509_58255, RNA815_6604} | |
| 52. | MligTC455_29200 | 404 | 8.42 | Mlig455_016456 | Neo: - Age: - |
OTOF | 1.685 | - | - | - | - | 0.975 | 0.710 | Mlig455_016456 {REF} {Length: 7086} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=232.5]; Ferlin C-terminus [PF16165.7, score=97.7]; FerB (NUC096) domain [PF08150.14, score=96.8]; FerI (NUC094) domain [PF08151.14, score=61.5]} {Human: ENSG00000115155, OTOF, otoferlin, [RH, Score=921, Expect=0.0]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [RH, Score=925, Expect=0.0]} {Dmel: FBgn0266757, mfr, misfire, [Score=308, Expect=5e-90]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=151, Expect=5e-36]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=1470, Expect=0.0]} {RNA1509_51560} {RNA1310_1416.6} {RNA815_411.1} |
| 53. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 1.679 | - | - | - | 0.721 | 0.958 | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
| 54. | MligTC455_14720 | 53 | 1.1 | Mlig455_033113 | Neo: - Age: - |
1.671 | - | - | 0.715 | - | 0.956 | - | Mlig455_033113 {REF} {Length: 2568} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=152.2]} {Celegans: WBGene00016063, delm-2, DEgenerin Linked to Mechanosensation, [Score=53.9, Expect=3e-07]} {Smed: dd_Smed_v6_16557_0_1, dd_Smed_v6_16557_0_1, [RH, Score=216, Expect=7e-63]} {RNA1310_23517.1} {RNA815_11158} | |
| 55. | MligTC455_54197 | 356 | 7.43 | Mlig455_020677, Mlig455_048758, Mlig455_059268 | Neo: - Age: - |
HVCN1 | 1.667 | - | - | - | 0.709 | 0.958 | - | Mlig455_020677 {REF} {Length: 2901} {Pfam: Ion transport protein [PF00520.33, score=23.6]} {Human: ENSG00000122986, HVCN1, hydrogen voltage gated channel 1, [Score=67.0, Expect=2e-11]} {Mouse: ENSMUSG00000064267, Hvcn1, hydrogen voltage-gated channel 1, [Score=66.2, Expect=2e-11]} {Smed: dd_Smed_v6_20053_0_1, dd_Smed_v6_20053_0_1, [Score=300, Expect=3e-94]} {RNA1310_10343} {RNA815_20707} Mlig455_048758 {REF} {Length: 1647} {Smed: dd_Smed_v6_16233_0_1, dd_Smed_v6_16233_0_1, [Score=88.2, Expect=1e-19]} {RNA1310_11204} {RNA815_20707} Mlig455_059268 {REF} {Length: 2414} {Pfam: Ion transport protein [PF00520.33, score=23.7]} {Human: ENSG00000122986, HVCN1, hydrogen voltage gated channel 1, [Score=67.4, Expect=1e-11]} {Mouse: ENSMUSG00000064267, Hvcn1, hydrogen voltage-gated channel 1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_20053_0_1, dd_Smed_v6_20053_0_1, [Score=298, Expect=1e-93]} {RNA1310_11204} {RNA815_20707} |
| 56. | MligTC455_38198 | 406 | 8.47 | Mlig455_034893 | Neo: - Age: - |
PHACTR4 | 1.665 | - | - | - | - | 0.964 | 0.701 | Mlig455_034893 {REF} {Length: 2589} {Pfam: RPEL repeat [PF02755.17, score=55.7]} {Human: ENSG00000204138, PHACTR4, phosphatase and actin regulator 4, [Score=172, Expect=5e-46]; ENSG00000112419, PHACTR2, phosphatase and actin regulator 2, [Score=168, Expect=5e-45]} {Mouse: ENSMUSG00000062866, Phactr2, phosphatase and actin regulator 2, [Score=171, Expect=2e-46]; ENSMUSG00000066043, Phactr4, phosphatase and actin regulator 4, [Score=163, Expect=3e-43]} {Dmel: FBgn0052264, CG32264, [Score=156, Expect=4e-42]} {Celegans: WBGene00009174, F26H9.2, [Score=154, Expect=3e-41]} {Smed: dd_Smed_v6_5826_0_1, dd_Smed_v6_5826_0_1, [Score=167, Expect=2e-45]} {RNA1509_52377} {RNA1310_5030.1} {RNA815_7774} |
| 57. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 1.661 | - | - | - | 0.709 | 0.952 | - | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
| 58. | MligTC455_05720 | 156 | 3.26 | Mlig455_040120 | Neo: - Age: - |
CHRNB3 | 0.977 | - | - | - | - | 0.977 | - | Mlig455_040120 {REF} {Length: 1839} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=90.2]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=205, Expect=1e-59]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=204, Expect=4e-59]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=197, Expect=3e-56]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=197, Expect=3e-56]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=196, Expect=7e-56]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=206, Expect=5e-60]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=201, Expect=5e-58]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=197, Expect=4e-57]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=204, Expect=3e-59]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=201, Expect=5e-58]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=364, Expect=8e-120]} {RNA1310_53963} {RNA815_48325} |
| 59. | MligTC455_24654 | 134 | 2.8 | Mlig455_033249 | Neo: - Age: - |
0.975 | - | - | - | - | - | 0.975 | Mlig455_033249 {REF} {Length: 1015} {NoTransDecoderORF} {RNA1310_65661.1} {RNA815_41693} | |
| 60. | MligTC455_14829 | 56 | 1.17 | Mlig455_053237 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.599 Region-enriched R2: 3.828/0.03404 |
SSUH2 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_053237 {REF} {Length: 1420} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=156, Expect=2e-43]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=117, Expect=2e-29]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=87.4, Expect=9e-19]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
| 61. | MligTC455_35505 | 126 | 2.62 | Mlig455_018997, Mlig455_022533, Mlig455_055707 | Neo: - Age: - |
HRH2, SYT7 | 0.971 | - | - | - | - | 0.971 | - | Mlig455_018997 {REF} {Length: 4854} {Pfam: C2 domain [PF00168.32, score=156.5]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=271, Expect=9e-84]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=261, Expect=3e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=4e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=6e-60]} {RNA1310_29722} {RNA815_16467} Mlig455_022533 {REF} {Length: 1223} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=80.1]} {Human: ENSG00000113749, HRH2, histamine receptor H2, [Score=68.6, Expect=4e-12]} {Mouse: ENSMUSG00000044338, Aplnr, apelin receptor, [Score=64.3, Expect=7e-11]; ENSMUSG00000037424, Taar9, trace amine-associated receptor 9, [Score=63.9, Expect=9e-11]; ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=63.2, Expect=2e-10]} {Dmel: FBgn0039595, AstA-R2, Allatostatin A receptor 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [Score=63.2, Expect=9e-11]} Mlig455_055707 {REF} {Length: 2803} {Pfam: C2 domain [PF00168.32, score=156.6]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=270, Expect=2e-83]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=259, Expect=4e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=2e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=4e-60]} {RNA1310_29722} {RNA815_16467} |
| 62. | MligTC455_38966 | 79 | 1.65 | Mlig455_032200, Mlig455_054191 | Neo: - Age: Up-Down-Down |
UTRN | 0.971 | - | - | - | - | 0.971 | - | Mlig455_032200 {REF} {Length: 2203} {Human: ENSG00000152818, UTRN, utrophin, [Score=65.9, Expect=8e-12]} {Mouse: ENSMUSG00000019820, Utrn, utrophin, [Score=62.8, Expect=6e-11]} {Dmel: FBgn0260003, Dys, Dystrophin, [Score=58.2, Expect=1e-09]} {Smed: dd_Smed_v6_5325_0_1, dd_Smed_v6_5325_0_1, [Score=91.3, Expect=4e-21]} {RNA1509_38827} {RNA1310_32833} {RNA815_17087} Mlig455_054191 {REF} {Length: 7646} {Pfam: EF-hand [PF09069.13, score=126.3]; EF hand [PF09068.13, score=102.4]; Zinc finger, ZZ type [PF00569.19, score=36.5]; WW domain [PF00397.28, score=19.9]} {Human: ENSG00000152818, UTRN, utrophin, [RH, Score=493, Expect=2e-140]; ENSG00000198947, DMD, dystrophin, [RH, Score=491, Expect=8e-145]} {Mouse: ENSMUSG00000045103, Dmd, dystrophin, muscular dystrophy, [RH, Score=488, Expect=4e-139]; ENSMUSG00000019820, Utrn, utrophin, [RH, Score=485, Expect=5e-138]} {Dmel: FBgn0260003, Dys, Dystrophin, [RH, Score=520, Expect=1e-155]} {Celegans: WBGene00001131, dys-1, Dystrophin-1, [RH, Score=344, Expect=1e-94]} {Smed: dd_Smed_v6_5325_0_3, dd_Smed_v6_5325_0_3, [RH, Score=302, Expect=7e-82]} {RNA1509_38827} {RNA1310_24533} {RNA815_12379} |
| 63. | MligTC455_41180 | 128 | 2.66 | Mlig455_048529 | Neo: - Age: - Region-enriched R2: 3.286/0.00629 |
0.969 | - | - | - | - | 0.969 | - | Mlig455_048529 {REF} {Length: 672} {NoTransDecoderORF} {RNA1310_69878} {RNA815_35715} | |
| 64. | MligTC455_24653 | 152 | 3.16 | Mlig455_003832 | Neo: - Age: logFC(26M/2M)=-0.444 |
AC270292.3 | 0.968 | - | - | - | - | - | 0.968 | Mlig455_003832 {REF} {Length: 6722} {Pfam: Poly(ADP-ribose) polymerase catalytic domain [PF00644.22, score=81.5]; Nin one binding (NOB1) Zn-ribbon like [PF08772.13, score=20.4]} {Human: ENSG00000285372, AC270292.3, tankyrase, [Score=72.4, Expect=5e-12]; ENSG00000173273, TNKS, tankyrase, [Score=72.4, Expect=5e-12]} {Mouse: ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=72.0, Expect=4e-12]} {Dmel: FBgn0027508, Tnks, tankyrase, [Score=64.7, Expect=6e-10]} {Celegans: WBGene00004049, parp-1, Poly(ADP-ribose) polymerase pme-1, [Score=52.4, Expect=2e-06]} {Smed: dd_Smed_v6_8547_0_1, dd_Smed_v6_8547_0_1, [Score=71.2, Expect=3e-12]} {RNA1509_34061} {RNA1310_5037} {RNA815_3497} |
| 65. | MligTC455_39207 | 161 | 3.36 | Mlig455_043588 | Neo: - Age: logFC(26M/2M)=-0.502 |
DCHS1 | 0.968 | - | - | - | - | 0.968 | - | Mlig455_043588 {REF} {Length: 8241} {Pfam: Cadherin domain [PF00028.19, score=487.6]; Cadherin-like [PF08266.14, score=41.6]; Cadherin-like [PF16184.7, score=29.4]; RET Cadherin like domain 1 [PF17756.3, score=27.8]} {Human: ENSG00000166341, DCHS1, dachsous cadherin-related 1, [Score=391, Expect=4e-110]; ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=375, Expect=5e-105]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=380, Expect=1e-106]; ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=378, Expect=3e-106]} {Dmel: FBgn0284247, ds, dachsous, [Score=418, Expect=3e-119]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=201, Expect=1e-51]} {Smed: dd_Smed_v6_11744_0_1, dd_Smed_v6_11744_0_1, [Score=179, Expect=5e-45]} {RNA1509_5448} {RNA1310_281} {RNA815_2365} |
| 66. | MligTC455_10354 | 51 | 1.05 | Mlig455_041267 | Neo: - Age: Up-Down-Down |
STOM | 0.966 | - | - | - | - | 0.966 | - | Mlig455_041267 {REF} {Length: 3318} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=115.0]; SPFH domain-Band 7 family [PF13421.8, score=21.0]} {Human: ENSG00000148175, STOM, stomatin, [RH, Score=355, Expect=5e-123]} {Mouse: ENSMUSG00000026880, Stom, stomatin, [Score=349, Expect=8e-121]} {Dmel: FBgn0260657, CG42540, [Score=362, Expect=1e-122]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [RH, Score=382, Expect=3e-132]} {Smed: dd_Smed_v6_6396_0_1, dd_Smed_v6_6396_0_1, [RH, Score=428, Expect=2e-152]} {RNA1509_58645} {RNA1310_19440.1} {RNA815_9049.1} |
| 67. | MligTC455_17089 | 173 | 3.6 | Mlig455_022974 | Neo: - Age: - Region-enriched R4: 2.568/0.01700 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_022974 {REF} {Length: 1697} {RNA1509_56619} {RNA1310_21133.1} {RNA815_8631.1} | |
| 68. | MligTC455_46446 | 44 | 0.92 | Mlig455_064208 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_064208 {REF} {Length: 608} {RNA1509_14730} {RNA1310_29088} {RNA815_18139} | |
| 69. | MligTC455_06948 | 11 | 0.23 | Mlig455_043252 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_043252 {REF} {Length: 734} {TRANSSPLICED} {RNA1509_49118} {RNA1310_24738.1} {RNA815_3785.1} | |
| 70. | MligTC455_20332 | 34 | 0.71 | Mlig455_038515 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_038515 {REF} {Length: 2092} {RNA1509_52468} {RNA1310_41235} {RNA815_11414.1} | |
| 71. | MligTC455_28786 | 36 | 0.76 | Mlig455_060723 | Neo: - Age: - |
ANKRD17 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_060723 {REF} {Length: 6125} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=81.7]; Ankyrin repeats (many copies) [PF13857.8, score=61.4]; Ankyrin repeats (many copies) [PF13637.8, score=57.1]; Ankyrin repeat [PF13606.8, score=49.1]; Ankyrin repeat [PF00023.32, score=45.2]; Mab-21 protein [PF03281.16, score=26.5]} {Human: ENSG00000132466, ANKRD17, ankyrin repeat domain 17, [Score=80.9, Expect=1e-14]; ENSG00000131503, ANKHD1, ankyrin repeat and KH domain containing 1, [Score=80.9, Expect=1e-14]; ENSG00000254996, ANKHD1-EIF4EBP3, ANKHD1-EIF4EBP3 readthrough, [Score=80.1, Expect=2e-14]; ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=80.1, Expect=2e-14]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=81.3, Expect=5e-15]; ENSMUSG00000055204, Ankrd17, ankyrin repeat domain 17, [Score=80.5, Expect=1e-14]; ENSMUSG00000024483, Ankhd1, ankyrin repeat and KH domain containing 1, [Score=77.8, Expect=9e-14]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=74.7, Expect=5e-13]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=66.6, Expect=1e-10]} {Smed: dd_Smed_v6_6779_0_1, dd_Smed_v6_6779_0_1, [Score=87.0, Expect=5e-17]} {RNA1509_26281} {RNA1310_4721} {RNA815_5358.1} |
| 72. | MligTC455_28994 | 66 | 1.38 | Mlig455_030538 | Neo: - Age: Up-Down-Up |
SIX1 | 0.962 | - | 0.962 | - | - | - | - | Mlig455_030538 {REF} {Length: 3445} {TRANSSPLICED} {Pfam: Transcriptional regulator, SIX1, N-terminal SD domain [PF16878.7, score=146.9]; Homeodomain [PF00046.31, score=55.9]; Homeobox KN domain [PF05920.13, score=48.0]} {Human: ENSG00000126778, SIX1, SIX homeobox 1, [Score=313, Expect=1e-103]; ENSG00000170577, SIX2, SIX homeobox 2, [Score=307, Expect=4e-101]} {Mouse: ENSMUSG00000051367, Six1, sine oculis-related homeobox 1, [Score=313, Expect=9e-104]; ENSMUSG00000024134, Six2, sine oculis-related homeobox 2, [Score=307, Expect=2e-101]} {Dmel: FBgn0003460, so, sine oculis, [Score=303, Expect=3e-98]} {Celegans: WBGene00000454, ceh-33, Homeobox protein ceh-33, [RH, Score=246, Expect=3e-78]} {Smed: dd_Smed_v6_15436_0_1, dd_Smed_v6_15436_0_1, [RH, Score=328, Expect=2e-107]} {RNA1509_55511} {RNA1310_27700} {RNA815_16067} |
| 73. | MligTC455_46173 | 63 | 1.3 | Mlig455_032091 | Neo: Irradiation Age: Up-Down-Up |
SRR | 0.962 | - | - | - | - | 0.962 | - | Mlig455_032091 {REF} {Length: 2590} {Pfam: Pyridoxal-phosphate dependent enzyme [PF00291.27, score=208.5]; ACT domain [PF01842.27, score=19.8]} {Human: ENSG00000167720, SRR, serine racemase, [Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000001323, Srr, serine racemase, [Score=105, Expect=4e-24]} {Dmel: FBgn0037684, CG8129, [Score=373, Expect=5e-123]} {Celegans: WBGene00010456, K01C8.1, [Score=407, Expect=5e-136]} {Smed: dd_Smed_v6_6737_0_1, dd_Smed_v6_6737_0_1, [Score=474, Expect=7e-163]} {RNA1509_48789} {RNA1310_15074} {RNA815_9364} |
| 74. | MligTC455_46402 | 134 | 2.8 | Mlig455_014535, Mlig455_017644 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_014535 {REF} {Length: 597} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_50941.2} {RNA815_26807} Mlig455_017644 {REF} {Length: 266} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_109876} {RNA815_26807} |
|
| 75. | MligTC455_22321 | 773 | 16.1 | Mlig455_006890, Mlig455_017894, Mlig455_017901, Mlig455_017905 | Neo: - Age: Up-Down-Down |
UNC13A, UNC13B | 0.96 | - | - | - | - | 0.960 | - | Mlig455_006890 {REF} {Length: 8483} {Pfam: MUN domain [PF06292.19, score=460.4]; C2 domain [PF00168.32, score=165.9]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=40.1]} {Human: ENSG00000198722, UNC13B, unc-13 homolog B, [RH, Score=1600, Expect=0.0]; ENSG00000130477, UNC13A, unc-13 homolog A, [RH, Score=1590, Expect=0.0]} {Mouse: ENSMUSG00000028456, Unc13b, unc-13 homolog B, [RH, Score=1595, Expect=0.0]; ENSMUSG00000034799, Unc13a, unc-13 homolog A, [RH, Score=1590, Expect=0.0]} {Dmel: FBgn0025726, unc-13, [RH, Score=1701, Expect=0.0]} {Celegans: WBGene00006752, unc-13, Phorbol ester/diacylglycerol-binding protein unc-13, [RH, Score=1489, Expect=0.0]} {Smed: dd_Smed_v6_11981_0_1, dd_Smed_v6_11981_0_1, [RH, Score=1793, Expect=0.0]} {RNA1509_25617} {RNA1310_453.1, RNA1509_25617} {RNA1509_25617, RNA815_1396} Mlig455_017894 {REF} {Length: 10746} {Pfam: MUN domain [PF06292.19, score=459.7]; C2 domain [PF00168.32, score=146.8]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=39.7]} {Human: ENSG00000130477, UNC13A, unc-13 homolog A, [RH, Score=1583, Expect=0.0]; ENSG00000198722, UNC13B, unc-13 homolog B, [RH, Score=1581, Expect=0.0]} {Mouse: ENSMUSG00000034799, Unc13a, unc-13 homolog A, [RH, Score=1584, Expect=0.0]; ENSMUSG00000028456, Unc13b, unc-13 homolog B, [RH, Score=1576, Expect=0.0]} {Dmel: FBgn0025726, unc-13, [RH, Score=1668, Expect=0.0]} {Celegans: WBGene00006752, unc-13, Phorbol ester/diacylglycerol-binding protein unc-13, [RH, Score=1459, Expect=0.0]} {Smed: dd_Smed_v6_11981_0_1, dd_Smed_v6_11981_0_1, [RH, Score=1753, Expect=0.0]} {RNA1509_45330} {RNA1310_1692} {RNA815_1396} Mlig455_017901 {REF} {Length: 7140} {Pfam: MUN domain [PF06292.19, score=460.5]; C2 domain [PF00168.32, score=136.3]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=40.6]} {Human: ENSG00000130477, UNC13A, unc-13 homolog A, [RH, Score=1582, Expect=0.0]; ENSG00000198722, UNC13B, unc-13 homolog B, [RH, Score=1579, Expect=0.0]} {Mouse: ENSMUSG00000034799, Unc13a, unc-13 homolog A, [RH, Score=1583, Expect=0.0]; ENSMUSG00000028456, Unc13b, unc-13 homolog B, [RH, Score=1574, Expect=0.0]} {Dmel: FBgn0025726, unc-13, [RH, Score=1667, Expect=0.0]} {Celegans: WBGene00006752, unc-13, Phorbol ester/diacylglycerol-binding protein unc-13, [RH, Score=1456, Expect=0.0]} {Smed: dd_Smed_v6_11981_0_1, dd_Smed_v6_11981_0_1, [RH, Score=1746, Expect=0.0]} {RNA1509_16665} {RNA1310_453.1} {RNA815_1396} Mlig455_017905 {REF} {Length: 3674} {Pfam: C2 domain [PF00168.32, score=35.8]} {Human: ENSG00000130477, UNC13A, unc-13 homolog A, [Score=166, Expect=5e-41]} {Mouse: ENSMUSG00000034799, Unc13a, unc-13 homolog A, [Score=162, Expect=5e-40]; ENSMUSG00000028456, Unc13b, unc-13 homolog B, [Score=155, Expect=1e-37]} {Celegans: WBGene00006752, unc-13, Phorbol ester/diacylglycerol-binding protein unc-13, [Score=174, Expect=9e-44]} {Smed: dd_Smed_v6_11981_0_1, dd_Smed_v6_11981_0_1, [Score=207, Expect=3e-54]} {RNA1509_45330} {RNA1310_453.1} {RNA815_23416} |
| 76. | MligTC455_51536 | 78 | 1.62 | Mlig455_040699 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_040699 {REF} {Length: 2015} {RNA1310_34295.1} {RNA815_22630} | |
| 77. | MligTC455_08774 | 25 | 0.53 | Mlig455_001889 | Neo: - Age: Up-Down-Down |
HCRTR2 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_001889 {REF} {Length: 3436} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=160.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=24.1]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=215, Expect=2e-63]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [RH, Score=212, Expect=1e-62]} {Dmel: FBgn0038874, ETHR, [Score=142, Expect=6e-37]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=116, Expect=6e-28]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=202, Expect=1e-59]} {RNA1310_31833} {RNA815_15909} |
| 78. | MligTC455_17197 | 170 | 3.54 | Mlig455_053652 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_053652 {REF} {Length: 2429} {TRANSSPLICED} {RNA1509_44480} {RNA1310_34935, RNA1509_44480} {RNA1509_44480, RNA815_20343} | |
| 79. | MligTC455_40938 | 28 | 0.57 | Mlig455_002890 | Neo: - |
PRKAR2A | 0.959 | - | - | - | - | 0.959 | - | Mlig455_002890 {REF} {Length: 3559} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=61.4]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=53.5, Expect=8e-07]; ENSG00000185532, PRKG1, protein kinase cGMP-dependent 1, [Score=51.2, Expect=4e-06]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=53.1, Expect=8e-07]; ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=51.2, Expect=5e-06]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=154, Expect=2e-39]} {RNA1509_30289} {RNA1310_5962} {RNA815_9809} |
| 80. | MligTC455_52983 | 56 | 1.16 | Mlig455_051283 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_051283 {REF} {Length: 785} {NoTransDecoderORF} {RNA1509_10121} {RNA1310_96060} {RNA815_42566} | |
| 81. | MligTC455_12776 | 17 | 0.36 | Mlig455_064082 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_064082 {REF} {Length: 2904} {RNA1310_64520} {RNA815_36721} | |
| 82. | MligTC455_33745 | 48 | 0.99 | Mlig455_057348, Mlig455_059577 | Neo: - Age: - |
NFIA, NFIC | 0.957 | - | - | - | - | - | 0.957 | Mlig455_057348 {REF} {Length: 2692} {TRANSSPLICED} {Human: ENSG00000141905, NFIC, nuclear factor I C, [RH, Score=99.4, Expect=4e-21]; ENSG00000162599, NFIA, nuclear factor I A, [RH, Score=98.6, Expect=7e-21]; ENSG00000147862, NFIB, nuclear factor I B, [RH, Score=96.3, Expect=5e-20]} {Mouse: ENSMUSG00000055053, Nfic, nuclear factor I/C, [RH, Score=98.6, Expect=3e-21]; ENSMUSG00000028565, Nfia, nuclear factor I/A, [RH, Score=98.6, Expect=4e-21]; ENSMUSG00000008575, Nfib, nuclear factor I/B, [RH, Score=96.3, Expect=4e-20]} {Dmel: FBgn0042696, NfI, Nuclear factor I, [RH, Score=95.5, Expect=8e-20]} {Celegans: WBGene00003592, nfi-1, NFI (Nuclear Factor I) family, [RH, Score=107, Expect=1e-23]} {Smed: dd_Smed_v6_12312_0_1, dd_Smed_v6_12312_0_1, [RH, Score=174, Expect=1e-44]} {RNA1509_19363} {RNA1310_11787} {RNA815_4938.1} Mlig455_059577 {REF} {Length: 4914} {TRANSSPLICED} {Human: ENSG00000162599, NFIA, nuclear factor I A, [RH, Score=98.6, Expect=7e-21]; ENSG00000147862, NFIB, nuclear factor I B, [RH, Score=96.3, Expect=5e-20]; ENSG00000141905, NFIC, nuclear factor I C, [RH, Score=96.3, Expect=4e-20]} {Mouse: ENSMUSG00000028565, Nfia, nuclear factor I/A, [RH, Score=98.6, Expect=4e-21]; ENSMUSG00000008575, Nfib, nuclear factor I/B, [RH, Score=96.3, Expect=4e-20]; ENSMUSG00000055053, Nfic, nuclear factor I/C, [RH, Score=95.9, Expect=2e-20]} {Dmel: FBgn0042696, NfI, Nuclear factor I, [RH, Score=95.5, Expect=8e-20]} {Celegans: WBGene00003592, nfi-1, NFI (Nuclear Factor I) family, [RH, Score=107, Expect=1e-23]} {Smed: dd_Smed_v6_12312_0_1, dd_Smed_v6_12312_0_1, [RH, Score=174, Expect=1e-44]} {RNA1509_19363} {RNA1310_11787} {RNA815_4938.1} |
| 83. | MligTC455_27673 | 123 | 2.56 | Mlig455_041241, Mlig455_053095 | Neo: - Age: Up-Down-Up |
GLRA1, GLRA3 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_041241 {REF} {Length: 4857} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=165.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.7]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=253, Expect=3e-78]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=9e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=246, Expect=1e-75]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=246, Expect=7e-76]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=244, Expect=2e-74]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=243, Expect=1e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=240, Expect=2e-73]} {Dmel: FBgn0024963, GluClalpha, [Score=256, Expect=1e-79]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [RH, Score=247, Expect=6e-76]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=440, Expect=1e-151]} {RNA1509_35986} {RNA1310_28655} {RNA815_20247} Mlig455_053095 {REF} {Length: 4892} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=163.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=83.4]} {Human: ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=254, Expect=9e-79]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=251, Expect=1e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=243, Expect=9e-75]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=9e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=244, Expect=5e-75]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=242, Expect=4e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=236, Expect=2e-72]} {Dmel: FBgn0024963, GluClalpha, [Score=257, Expect=4e-80]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=252, Expect=3e-78]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=449, Expect=1e-155]} {RNA1509_54479} {RNA1310_56579} {RNA815_20247} |
| 84. | MligTC455_33292 | 128 | 2.67 | Mlig455_051418 | Neo: - Age: - |
CERKL | 0.956 | - | - | - | - | 0.956 | - | Mlig455_051418 {REF} {Length: 4732} {TRANSSPLICED} {Pfam: Diacylglycerol kinase catalytic domain [PF00781.26, score=53.4]; Ceramide kinase C-terminal domain [PF19280.1, score=36.5]} {Human: ENSG00000188452, CERKL, ceramide kinase like, [Score=109, Expect=3e-24]} {Mouse: ENSMUSG00000075256, Cerkl, ceramide kinase-like, [Score=97.4, Expect=1e-20]} {Dmel: FBgn0037315, Cerk, Ceramide kinase, [Score=97.8, Expect=1e-20]} {Smed: dd_Smed_v6_9323_0_1, dd_Smed_v6_9323_0_1, [Score=122, Expect=5e-29]} {RNA1509_27178} {RNA1310_5866.1} {RNA815_1765} |
| 85. | MligTC455_37557 | 184 | 3.84 | Mlig455_004005 | Neo: - Age: - |
SLC16A12 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_004005 {REF} {Length: 2674} {Pfam: Major Facilitator Superfamily [PF07690.18, score=122.4]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=52.2]; Vacuole effluxer Atg22 like [PF11700.10, score=25.3]} {Human: ENSG00000152779, SLC16A12, solute carrier family 16 member 12, [RH, Score=192, Expect=1e-54]} {Mouse: ENSMUSG00000009378, Slc16a12, solute carrier family 16 (monocarboxylic acid transporters), member 12, [Score=194, Expect=7e-56]} {Dmel: FBgn0023549, Mct1, Monocarboxylate transporter 1, [Score=169, Expect=5e-46]} {Celegans: WBGene00015676, mct-6, MonoCarboxylate Transporter family, [Score=156, Expect=2e-41]} {Smed: dd_Smed_v6_9402_0_1, dd_Smed_v6_9402_0_1, [Score=181, Expect=1e-50]} {RNA1509_33139} {RNA1310_17032} {RNA815_6570} |
| 86. | MligTC455_14495 | 35 | 0.72 | Mlig455_035547 | Neo: - Age: logFC(26M/2M)=-0.455 |
ANKEF1 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_035547 {REF} {Length: 2582} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=159.3]; Ankyrin repeats (many copies) [PF13637.8, score=132.9]; Ankyrin repeat [PF13606.8, score=111.4]; Ankyrin repeats (many copies) [PF13857.8, score=106.3]; Ankyrin repeat [PF00023.32, score=97.4]} {Human: ENSG00000132623, ANKEF1, ankyrin repeat and EF-hand domain containing 1, [Score=437, Expect=6e-143]} {Mouse: ENSMUSG00000074771, Ankef1, ankyrin repeat and EF-hand domain containing 1, [Score=434, Expect=1e-141]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=96.3, Expect=3e-20]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=80.9, Expect=2e-15]} {Smed: dd_Smed_v6_12476_0_1, dd_Smed_v6_12476_0_1, [Score=577, Expect=0.0]} {RNA1509_22782, RNA1509_32129} {RNA1310_8283, RNA1509_32129} {RNA1509_32129, RNA815_2494.1} |
| 87. | MligTC455_32422 | 37 | 0.78 | Mlig455_031348 | Neo: - Age: - |
CHRNA6 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_031348 {REF} {Length: 1659} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=69.7]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=61.6, Expect=5e-10]; ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=61.2, Expect=8e-10]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=61.2, Expect=5e-10]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=60.8, Expect=8e-10]; ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=58.5, Expect=4e-09]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=48.5, Expect=4e-06]} {Celegans: WBGene00000057, acr-18, AcetylCholine Receptor; Acetylcholine receptor, one of nine alpha a7-like nicotinic acetylcholine receptor subunits (58.6 kD) (Acr-18), [Score=63.5, Expect=5e-11]} {Smed: dd_Smed_v6_30253_0_1, dd_Smed_v6_30253_0_1, [Score=59.3, Expect=6e-10]} {RNA1310_61084} {RNA815_48984} |
| 88. | MligTC455_45848 | 222 | 4.63 | Mlig455_042113 | Neo: - Age: - Region-enriched R5: 3.022/0.00028 |
0.953 | - | - | - | 0.953 | - | - | Mlig455_042113 {REF} {Length: 2021} {RNA1509_1392} {RNA1310_1560.1} {RNA815_476} | |
| 89. | MligTC455_47315 | 116 | 2.42 | Mlig455_017232 | Neo: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_017232 {REF} {Length: 1840} {RNA1509_52985} {RNA1310_31050.1} {RNA815_38830} | |
| 90. | MligTC455_05124 | 30 | 0.63 | Mlig455_013049 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_013049 {REF} {Length: 875} {Pfam: Lectin C-type domain [PF00059.23, score=28.5]} {RNA1509_20946} {RNA1310_85223} {RNA815_4785.4} | |
| 91. | MligTC455_19298 | 52 | 1.08 | Mlig455_007404 | Neo: - Age: - |
IRX4 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_007404 {REF} {Length: 1775} {Pfam: Homeobox KN domain [PF05920.13, score=53.9]; Homeodomain [PF00046.31, score=30.1]} {Human: ENSG00000113430, IRX4, iroquois homeobox 4, [RH, Score=149, Expect=2e-39]; ENSG00000159387, IRX6, iroquois homeobox 6, [RH, Score=147, Expect=6e-39]} {Mouse: ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [RH, Score=150, Expect=5e-40]; ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [RH, Score=145, Expect=1e-38]} {Dmel: FBgn0015919, caup, caupolican, [RH, Score=153, Expect=3e-40]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [RH, Score=124, Expect=1e-31]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [RH, Score=159, Expect=3e-44]} {RNA1310_58105} {RNA815_61910} |
| 92. | MligTC455_31396 | 20 | 0.42 | Mlig455_005971 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_005971 {REF} {Length: 3224} {RNA1310_47894} {RNA815_41556} | |
| 93. | MligTC455_07327 | 46 | 0.95 | Mlig455_001874, Mlig455_001949 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_001874 {REF} {Length: 1082} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.3]} {Celegans: WBGene00019444, frpr-11, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.4, Expect=3e-09]} {RNA1310_94087} {RNA815_48529} Mlig455_001949 {REF} {Length: 2058} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.4]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.0, Expect=4e-09]} {RNA1509_46461} {RNA1310_94087} {RNA815_57978} |
|
| 94. | MligTC455_18988 | 84 | 1.76 | Mlig455_063835 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.612 Region-enriched R4: 4.537/0.00889 |
SYN3 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_063835 {REF} {Length: 2341} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=194.6]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.0]} {Human: ENSG00000185666, SYN3, synapsin III, [Score=188, Expect=4e-53]; ENSG00000157152, SYN2, synapsin II, [Score=185, Expect=2e-55]; ENSG00000008056, SYN1, synapsin I, [Score=184, Expect=8e-51]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [Score=191, Expect=4e-54]; ENSMUSG00000037217, Syn1, synapsin I, [Score=186, Expect=2e-51]; ENSMUSG00000009394, Syn2, synapsin II, [Score=185, Expect=7e-53]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=159, Expect=7e-43]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=115, Expect=3e-28]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [RH, Score=177, Expect=2e-51]} {RNA1310_16093.1} {RNA815_2386} |
| 95. | MligTC455_29824 | 15 | 0.31 | Mlig455_052358 | Neo: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_052358 {REF} {Length: 2784} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=40.6]; GIY-YIG catalytic domain [PF01541.26, score=19.6]} {Smed: dd_Smed_v6_129_2_1, dd_Smed_v6_129_2_1, [RH, Score=268, Expect=8e-81]} {RNA1509_58257} {RNA1310_26667} {RNA815_13375.1} | |
| 96. | MligTC455_40065 | 58 | 1.22 | Mlig455_069280 | Neo: - Age: Up-Down-Up |
0.951 | - | - | - | - | 0.951 | - | Mlig455_069280 {REF} {Length: 3092} {Pfam: Coiled-coil domain-containing protein 154 [PF15450.8, score=35.7]; Apolipoprotein A1/A4/E domain [PF01442.20, score=19.3]} {Smed: dd_Smed_v6_10236_0_1, dd_Smed_v6_10236_0_1, [Score=236, Expect=1e-67]} {RNA1509_48196} {RNA1310_30411, RNA1509_48196} {RNA1509_48196, RNA815_45200} | |
| 97. | MligTC455_47601 | 126 | 2.62 | Mlig455_056477 | Neo: - Age: Up-Down-Up |
NRXN1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_056477 {REF} {Length: 3481} {Pfam: Laminin G domain [PF02210.26, score=58.3]; Laminin G domain [PF00054.25, score=43.2]; Syndecan domain [PF01034.22, score=27.4]} {Human: ENSG00000179915, NRXN1, neurexin 1, [Score=142, Expect=4e-35]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=142, Expect=1e-35]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=102, Expect=2e-22]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [Score=142, Expect=8e-36]} {RNA1509_55888} {RNA1310_37025, RNA1509_55888} {RNA1509_55888, RNA815_22404} |
| 98. | MligTC455_26115 | 162 | 3.37 | Mlig455_009388 | Neo: - Age: Up-Down-Up |
0.95 | - | - | - | - | 0.950 | - | Mlig455_009388 {REF} {Length: 3949} {RNA1509_28486} {RNA1310_24343.1} {RNA815_8096} | |
| 99. | MligTC455_29323 | 239 | 4.98 | Mlig455_053598 | Neo: - Age: - |
NOTCH4 | 0.95 | - | 0.950 | - | - | - | - | Mlig455_053598 {REF} {Length: 4886} {Pfam: EGF-like domain [PF00008.29, score=147.1]; Human growth factor-like EGF [PF12661.9, score=87.2]; Ankyrin repeats (3 copies) [PF12796.9, score=85.5]; Ankyrin repeats (many copies) [PF13857.8, score=77.4]; Ankyrin repeat [PF00023.32, score=64.8]; Ankyrin repeats (many copies) [PF13637.8, score=64.3]; Ankyrin repeat [PF13606.8, score=59.4]; LNR domain [PF00066.19, score=53.5]; EGF-like domain [PF07974.15, score=44.0]; Calcium-binding EGF domain [PF07645.17, score=31.7]} {Human: ENSG00000235396, NOTCH4, notch 4, [Score=312, Expect=1e-87]; ENSG00000206312, NOTCH4, notch 4, [Score=312, Expect=1e-87]; ENSG00000234876, NOTCH4, notch 4, [Score=311, Expect=1e-87]; ENSG00000223355, NOTCH4, notch 4, [Score=311, Expect=1e-87]; ENSG00000204301, NOTCH4, notch 4, [Score=311, Expect=1e-87]; ENSG00000232339, NOTCH4, notch 4, [Score=311, Expect=1e-87]; ENSG00000134250, NOTCH2, notch 2, [Score=309, Expect=1e-86]; ENSG00000238196, NOTCH4, notch 4, [Score=297, Expect=1e-84]} {Mouse: ENSMUSG00000027878, Notch2, notch 2, [Score=349, Expect=5e-100]} {Dmel: FBgn0004647, N, Notch, [Score=332, Expect=1e-94]} {Celegans: WBGene00003001, lin-12, [Score=240, Expect=6e-65]} {Smed: dd_Smed_v6_7067_0_1, dd_Smed_v6_7067_0_1, [Score=239, Expect=2e-64]} {RNA1509_20447, RNA1509_57909} {RNA1310_1718.1, RNA1509_57909} {RNA1509_57909, RNA815_12429} |